# BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

> **NCT04091295** · — · AVAILABLE · sponsor: **Aveni Foundation**

## Conditions studied

- Pancreatic Cancer
- Osteosarcoma
- MPNST (Malignant Peripheral Nerve Sheath Tumor)
- Chondrosarcoma
- Soft Tissue Sarcoma
- Chordoma
- Sarcoma
- Carcinoma of Breast
- Single Patient IND for Glioblastoma, Ovarian Carcinoma, Non-small Cell Lung Cancer , Prostate Cancer

## Interventions

- **DRUG:** DNG64-CAR-V

## Key facts

- **NCT ID:** NCT04091295
- **Lead sponsor:** Aveni Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04091295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04091295, "BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04091295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*